首页|期刊导航|青岛大学学报(医学版)|ASCVD风险与阿尔茨海默病生物标志物及认知功能的关联

ASCVD风险与阿尔茨海默病生物标志物及认知功能的关联OA

Association of the risk of atherosclerotic cardiovascular disease with biomarkers for Alzheimer's disease and cognitive function

中文摘要英文摘要

目的 探讨动脉粥样硬化性心血管疾病(ASCVD)风险与阿尔茨海默病(AD)脑脊液(CSF)相关生物标志物及认知功能的关联.方法 纳入中国AD生物标志物和生活方式研究(CABLE)队列1 371例非痴呆受试者,应用美国心脏病学会和美国心脏协会ASCVD风险计算器计算10年ASCVD风险评分预测未来心血管疾病(CVD)的风险,根据ASCVD 10年风险评分将研究对象分为极低风险组(287例)、低风险组(255例)、中等风险组(371例)和高风险组(458例).采用多元线性回归模型分析ASCVD 10年风险评分和CSF中AD生物标志物淀粉样蛋白-β42(Aβ42)、总tau(T-tau)、磷酸化tau(P-tau)水平及简易智力状态检查(MMSE)、蒙特利尔认知评估(MoCA)评分的相关性,并进行中介分析探讨CSF AD生物标志物是否介导了 ASCVD风险与认知功能的关系.结果 ASCVD 10年风险评分与 CSF P-tau(β=0.199,P<0.001)、CSF T-tau(β=0.269,P<0.001)、CSF T-tau/Aβ42(β=0.132,P<0.001)及 CSF P-tau/Aβ42(β=0.069,P<0.05)呈正相关,与 CSF Aβ42 水平无显著关联(β=0.037,P>0.05),与 MMSE 评分(β=-0.168,P<0.001)和 MoCA 评分(β=-0.240,P<0.001)呈负相关.中介分析显示,tau相关标志物部分介导了 ASCVD风险对认知功能的影响.结论 非痴呆人群ASCVD 10年风险评分与CSF T-tau、P-tau呈正相关,CVD风险可能通过tau相关通路损害认知功能.

Objective To investigate the association of the risk of atherosclerotic cardiovascular disease(ASCVD)with cere-brospinal fluid(CSF)biomarkers for Alzheimer's disease(AD)and cognitive function.Methods A total of 1 371 non-dementia subjects were selected from the Chinese Alzheimer's Biomarker and Lifestyle(CABLE)study cohort.The 10-year ASCVD risk score was calculated using the American College of Cardiology/American Heart Association(ACC/AH A)Risk Estimator to pre-dict the risk of cardiovascular disease in the future,and according to the 10-year ASCVD risk score,the subjects were divided into very low risk group with 287 subjects,low risk group with 255 subjects,moderate risk group with 371 subjects,and high risk group with 458 subjects.The multiple linear regression model was used to analyze the association of 10-year ASCVD risk score with AD biomarkers in CSF(amyloid-β42(Aβ42),total tau(T-tau),and phosphorylated tau(P-tau)),Mini-Mental State Examination(MMSE)score,and Montreal Cognitive Assessment(MoCA)score,and the mediation effect analysis was used to assess whether CSF AD biomarkers mediated the association between ASCVD risk and cognitive function.Results The 10-year ASCVD risk score was positively associated with CSF P-tau(β=0.199,P<0.001),CSF T-tau(β=0.269,P<0.001),CSF T-tau/Aβ42(β=0.132,P<0.001),and CSF P-tau/Aβ42(β=0.069,P<0.05),was not significantly associated with CSF Aβ42(β=0.037,P>0.05),and was negatively associated with MMSE score(β=-0.168,P<0.001)and MoCA score(β=-0.240,P<0.001).The mediation effect analysis showed that tau-related biomarkers partially mediated the effect of ASCVD risk on cognitive function.Conclusion The 10-year ASCVD risk score is positively associated with CSF T-tau and P-tau in the non-dementia population,sug-gesting that the risk of cardiovascular diseases may impair cognitive function through the tau-related pathways.

邱淑东;谭兰

南京医科大学青岛市市立医院神经内科,山东青岛 266071南京医科大学青岛市市立医院神经内科,山东青岛 266071

医药卫生

阿尔茨海默病认知功能障碍Tau病变心血管疾病生物标记

Alzheimer diseasecognitive dysfunctiontauopathiescardiovascular diseasesbiomarkers

《青岛大学学报(医学版)》 2026 (3)

418-422,5

国家自然科学基金重大研究计划项目(82570-53551)

10.11712/jms.2096-5532.2026.62.104

评论